Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products

By Braakman E.   Schuurhuis Gj   Preijers Fwmb   Voermans C.   Theunissen K.   van Riet I.   Fibbe We   Slaper-Cortenbach I.  

Cytotherapy, Vol. 10, Iss. 1, 2007-12 ,pp. : 83-89

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Aldehyde dehydrogenase as an alternative to enumeration of total and viable CD34⁺⁺ cells in autologous hematopoietic progenitor cell transplantation

By Veeraputhiran Muthu   Katragadda Lakshmikanth   Balamurugan Appathurai   Cottler-Fox Michele  

Cytotherapy, Vol. 13, Iss. 10, 2011-11 ,pp. : 1256-1258

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Validation of the single-platform ISHAGE method for CD34⁺ hematopoietic stem and progenitor cell enumeration in an international multicenter study

By Gratama Jw   Kraan J   Keeney M   Sutherland Dr   Granger V   Barnett D  

Cytotherapy, Vol. 5, Iss. 1, 2003-01 ,pp. : 55-65

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Prediction of CD34 ⁺⁺ cell yield in hematopoietic cell products from children by peripheral blood CD34 ⁺⁺ cell counts

By Rujkijyanont Piya   Hipps John   Gan Kwan   Yang Jie   Wang Chong   Geiger Terrence L.   Eldridge Paul W.   Leung Wing  

Cytotherapy, Vol. 14, Iss. 4, 2012-04 ,pp. : 473-482

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Systematic investigation of oxygen and growth factors in clinically valid ex vivo expansion of cord blood CD34⁺ hematopoietic progenitor cells

By Tursky Melinda L.   Collier Fiona M.   Ward Alister C.   Kirkland Mark A.  

Cytotherapy, Vol. 14, Iss. 6, 2012-07 ,pp. : 679-685

Ashgate Publishing Ltd

Access to resources Recommend Favorite